“alzheon” Archives

in
Entry Author Date Location
Bio Roundup: Aimmune Drama, Shutdown Blues, Perlmutter Talks Cancer 01/18/19 National
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks 03/23/18 National
Alzheon Files for IPO to Fund Studies of Amyloid Alzheimer’s Drug 03/16/18 Boston
Bio Roundup: CBO’s Praise, Celgene’s Shock, Trump’s Opioid Plan & More 10/27/17 National
At Alzheimer’s Meeting, Firms Take Page From Silver Linings Playbook 07/29/16 National
Failed Alzheimer’s Drug To Get Another Shot, If Investors Pony Up 03/11/16 Boston
Alzheon Obtains $1,300,000 New Financing Round 02/29/16 Boston
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
Alzheon Gets $10M to Take Castoff Alzheimer’s Drug Into Pivotal Test 04/08/15 Boston
Alzheon Garners $10,000,000 Series A Financing 04/08/15 Boston
Alzheon Garners $4,294,629 New Round 02/26/15 Boston
Alzheon Obtains $3,050,000 New Funding 01/12/15 Boston
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
Alzheon Secures New Financing 10/24/13 Boston
Alzheon Emerges From Stealth, Hunts for Alzheimer’s Castoffs 10/23/13 Boston
Page 1 of 1